...
首页> 外文期刊>Molecular informatics >Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow
【24h】

Screening Chemicals for Receptor-Mediated Toxicological and Pharmacological Endpoints: Using Public Data to Build Screening Tools within a KNIME Workflow

机译:为受体介导的毒理学和药理学终点筛选化学药品:使用公共数据在KNIME工作流程中构建筛选工具

获取原文
获取原文并翻译 | 示例

摘要

Assessing compounds for their pharmacological and toxicological properties is of great importance for industry and regulatory agencies. In this study an approach using open source software and open access databases to build screening tools for receptor-mediated effects is presented. The retinoic acid receptor (RAR), as a pharmacologically and toxicologically relevant target, was chosen for this study. RAR agonists are used in the treatment of a number of dermal conditions and specific types of cancer, such as acute promyelocytic leukemia. However, when administered chronically, there is strong evidence that RAR agonists cause hepatosteatosis and liver injury. After compiling information on ligand-protein-interactions, common substructures and physico-chemical properties of ligands were identified manually and coded into SMARTS strings. Based on these SMARTS strings and calculated physico-chemical features, a rule-based screening workflow was built within the KNIME platform. The workflow was evaluated on two datasets: one with RAR agonists exclusively and another large, chemically diverse dataset containing only a few RAR agonists. Possible modifications and applications of screening workflows, dependent on their purpose, are presented.
机译:对化合物的药理和毒理特性进行评估对工业和监管机构而言非常重要。在这项研究中,提出了一种使用开源软件和开放访问数据库来构建针对受体介导作用的筛选工具的方法。本研究选择了视黄酸受体(RAR)作为药理和毒理学相关的靶标。 RAR激动剂用于治疗多种皮肤疾病和特定类型的癌症,例如急性早幼粒细胞白血病。然而,当长期给药时,有充分的证据表明RAR激动剂会引起肝硬脂病和肝损伤。在收集了有关配体-蛋白质相互作用的信息后,手动识别了配体的常见亚结构和理化性质,并将其编码为SMARTS字符串。基于这些SMARTS字符串和计算出的理化特征,在KNIME平台内构建了基于规则的筛选工作流程。在两个数据集上评估了工作流程:一个数据集仅包含RAR激动剂,另一个数据集包含多种RAR激动剂,其化学性质各异。介绍了筛选工作流程的可能修改和应用,具体取决于其目的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号